investor presentation friday 10am9 Feb 2021 13:44
MGC Pharmaceuticals Ltd (LSE: MXC, ASX: MXC, 'MGC Pharma' or 'the Company'), a European based and dual listed bio-pharma company specialising in the production and development of phytocannabinoid-derived medicines, is pleased to announce that Roby Zomer, CEO and Managing Director, and Brett Mitchell, Executive Chairman, will be presenting at an investor webinar being hosted jointly by Turner Pope Investments and Vox Markets.
MGC Pharma is the first medicinal cannabis company to be listed on the LSE.
The webinar will take place at 10am GMT (9pm Sydney) on Friday 12th February 2021. Please register your interest at https://**********.brand.live/c/vox-markets-and-turner-pope-webinar-friday-february-12th.